Cargando…
Combining Sodium Butyrate With Cisplatin Increases the Apoptosis of Gastric Cancer In Vivo and In Vitro via the Mitochondrial Apoptosis Pathway
Introduction: The gastrointestinal malignancy, gastric cancer (GC), has a high incidence worldwide. Cisplatin is a traditional chemotherapeutic drug that is generally applied to treat cancer; however, drug tolerance affects its efficacy. Sodium butyrate is an intestinal flora derivative that has gen...
Autores principales: | Li, Yangbo, He, Pengzhan, Liu, Yinghui, Qi, Mingming, Dong, Weiguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430036/ https://www.ncbi.nlm.nih.gov/pubmed/34512341 http://dx.doi.org/10.3389/fphar.2021.708093 |
Ejemplares similares
-
Hesperetin Promotes Cisplatin−Induced Apoptosis of Gastric Cancer In Vitro and In Vivo by Upregulating PTEN Expression
por: He, Pengzhan, et al.
Publicado: (2020) -
α-Hederin Increases The Apoptosis Of Cisplatin-Resistant Gastric Cancer Cells By Activating Mitochondrial Pathway In Vivo And Vitro
por: Liu, Yinghui, et al.
Publicado: (2019) -
Synergistic effects of sodium butyrate and cisplatin against cervical carcinoma in vitro and in vivo
por: Chu, Huijun, et al.
Publicado: (2022) -
Sodium butyrate-induced DAPK-mediated apoptosis in human gastric cancer cells
por: SHIN, HYUNSOO, et al.
Publicado: (2011) -
Sodium butyrate and tributyrin induce in vivo growth inhibition and apoptosis in human prostate cancer
por: Kuefer, R, et al.
Publicado: (2004)